DRUG

lobeglitazone

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for lobeglitazone

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
PPARγ pancreatic cancer 0.230 Mid novel signal none

Clinical trials

48 registered trials for lobeglitazone

Source: ClinicalTrials.gov

← All drugs